SP
THC icon

Saranac Partners’s Tenet Healthcare THC Stock Holding History

Saranac Partners’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$462K Sell
2,368
-95
-4% -$20K 0.2% 61
2025
Q4 		$489K Hold
2,463
– – 0.19% 52
2025
Q3 		$500K Buy
2,463
+210
+9% +$37.3K 0.09% 131
2025
Q2 		$397K Buy
2,253
+600
+36% +$90.3K 0.21% 55
2025
Q1 		$222K Buy
+1,653
New +$218K 0.13% 71
2024
Q3 		– Sell
-2,300
Closed -$306K – 62
2024
Q2 		$306K Hold
2,300
– – 0.18% 58
2024
Q1 		$242K Buy
+2,300
New +$207K 0.15% 71

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Saranac Partners's THC Position: Q1 2026 in Review

Saranac Partners reduced its Tenet Healthcare (THC) stake by 3.9% in Q1 2026, selling an estimated $20K and leaving 2,368 shares worth $462K. The position accounts for 0.2% of the portfolio, ranked #61.

Saranac Partners first reported a position in THC in Q1 2024 and has held it in 7 quarters since. The position peaked at $500K in Q3 2025. 692 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Saranac Partners held 2,368 shares of Tenet Healthcare worth $462K as of Q1 2026.
  • Saranac Partners sold 95 Tenet Healthcare shares in Q1 2026, an estimated $20K.
  • Tenet Healthcare made up 0.2% of Saranac Partners's portfolio in Q1 2026, its #61 holding.
  • Saranac Partners first reported a position in Tenet Healthcare in Q1 2024 and has held it in 7 quarters since.
  • Saranac Partners's Tenet Healthcare position peaked at $500K in Q3 2025.
  • 692 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Saranac Partners's 13F filing for Q1 2026, filed 15 May 2026.